Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$47.19 - $62.68 $80,223 - $106,556
-1,700 Reduced 28.81%
4,200 $220,000
Q1 2021

May 18, 2021

SELL
$53.26 - $68.08 $159,780 - $204,240
-3,000 Reduced 33.71%
5,900 $387,000
Q4 2020

Feb 17, 2021

SELL
$43.41 - $56.51 $247,436 - $322,107
-5,700 Reduced 39.04%
8,900 $501,000
Q3 2020

Nov 17, 2020

SELL
$47.43 - $60.75 $697,221 - $893,025
-14,700 Reduced 50.17%
14,600 $709,000
Q2 2020

Aug 17, 2020

BUY
$43.51 - $66.59 $1.27 Million - $1.95 Million
29,300 New
29,300 $1.63 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.